Passive exposure to nicotine from e-cigarettes
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
Gallart (2016)
Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus)
Non-Clinical
Genotoxicity
In Vitro
Galloway (2011)
Changes in Availability of ENDS: 2019-2020, U.S.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Gammon (2022)
adverse effects of electronic cigarettes on the disease-naive oral microbiome.
Individual Clinical
Safety
Adverse Effects
Ganesan (2020)
addressing the challenges of E-cigarette safety profiling by assessment of pulmonary toxicological response in bronchial and alveolar mucosa models.
Nonclinical
Cardiovascular Toxicity
In Vitro
Ganguly (2020)
associations between vaping and eating disorder diagnosis and risk among college students.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Ganson (2021)
Compulsive exercise and vaping among a sample of U.S. College students aged 18-26 years.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Ganson (2022)
a numerical study on capillary-evaporation behavior of porous wick in electronic cigarettes.
Nonclinical
Chemical
Analysis
Gao (2021)
Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner
Non-clinical
Safety Effects In Animals
Repeat-dose Toxicity
Garcia-arcos (2016)
Electronic Nicotine Delivery System (ENDS) Device Types and Flavors Used by Youth in the PATH Study, 2016-2019.
Population Clinical
Consumer Use
Youth Use & Appeal
Gardner (2022)